OWD
CVS icon

Osborn Williams & Donohoe’s CVS Health CVS Stock Holding History

Osborn Williams & Donohoe’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$9.47M Buy
159,691
+3,395
+2% +$227K 1.24% 21
2019
Q4 		$11.6M Sell
156,296
-11,610
-7% -$815K 1.16% 21
2019
Q3 		$10.6M Buy
167,906
+5,323
+3% +$315K 1.07% 26
2019
Q2 		$8.86M Buy
162,583
+20,067
+14% +$1.08M 0.91% 31
2019
Q1 		$7.51M Buy
142,516
+14,845
+12% +$916K 0.77% 35
2018
Q4 		$8.37M Buy
127,671
+3,343
+3% +$250K 1.48% 20
2018
Q3 		$9.79M Sell
124,328
-361
-0.3% -$25.8K 1.52% 18
2018
Q2 		$8.02M Buy
124,689
+11,335
+10% +$747K 1.36% 22
2018
Q1 		$7.05M Buy
113,354
+6,820
+6% +$489K 1.22% 25
2017
Q4 		$7.72M Buy
106,534
+3,754
+4% +$273K 1.32% 24
2017
Q3 		$8.36M Sell
102,780
-617
-0.6% -$48.8K 1.51% 17
2017
Q2 		$8.32M Buy
103,397
+3,928
+4% +$310K 1.51% 19
2017
Q1 		$7.81M Buy
99,469
+2,158
+2% +$172K 1.41% 23
2016
Q4 		$7.68M Buy
97,311
+2,480
+3% +$201K 1.44% 22
2016
Q3 		$8.44M Sell
94,831
-3,453
-4% -$326K 1.61% 14
2016
Q2 		$9.41M Buy
98,284
+797
+0.8% +$79.4K 1.83% 8
2016
Q1 		$10.1M Sell
97,487
-1,737
-2% -$169K 2.03% 5
2015
Q4 		$9.7M Buy
99,224
+1,520
+2% +$149K 2% 6
2015
Q3 		$9.63M Sell
97,704
-734
-0.7% -$77.2K 2.09% 5
2015
Q2 		$10.9M Sell
98,438
-7,412
-7% -$757K 2.19% 3
2015
Q1 		$10.9M Sell
105,850
-1,838
-2% -$186K 2.12% 3
2014
Q4 		$10.4M Sell
107,688
-1,709
-2% -$151K 2.03% 4
2014
Q3 		$8.71M Buy
109,397
+377
+0.3% +$29.7K 1.81% 9
2014
Q2 		$8.38M Buy
109,020
+867
+0.8% +$65.5K 1.73% 10
2014
Q1 		$8.1M Buy
108,153
+1,194
+1% +$84.3K 1.78% 9
2013
Q4 		$7.66M Buy
106,959
+2,349
+2% +$151K 1.72% 11
2013
Q3 		$5.94M Buy
104,610
+3,204
+3% +$191K 1.45% 14
2013
Q2 		$5.8M Buy
+101,406
New +$5.88M 1.51% 14

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Osborn Williams & Donohoe's CVS Position: Q1 2020 in Review

Osborn Williams & Donohoe increased its CVS Health (CVS) stake by 2.2% in Q1 2020, buying an estimated $227K and bringing the position to 159,691 shares worth $9.47M. The position accounts for 1.24% of the portfolio, ranked #21.

Osborn Williams & Donohoe first reported a position in CVS in Q2 2013 and has held it in 28 quarters since. The position peaked at $11.6M in Q4 2019. 1,817 funds tracked by Wall St. Rank hold CVS as of Q1 2020.

  • Osborn Williams & Donohoe held 159,691 shares of CVS Health worth $9.47M as of Q1 2020.
  • Osborn Williams & Donohoe bought 3,395 CVS Health shares in Q1 2020, an estimated $227K.
  • CVS Health made up 1.24% of Osborn Williams & Donohoe's portfolio in Q1 2020, its #21 holding.
  • Osborn Williams & Donohoe first reported a position in CVS Health in Q2 2013 and has held it in 28 quarters since.
  • Osborn Williams & Donohoe's CVS Health position peaked at $11.6M in Q4 2019.
  • 1,817 funds tracked by Wall St. Rank held CVS Health as of Q1 2020.

Based on Osborn Williams & Donohoe's 13F filing for Q1 2020, filed 4 May 2020.